Heron Therapeutics' stock price surge may be positive, but the company's core business performance will decide the sustainability of this turnaround. Lack of profitability and minimal revenue growth could discourage potential investors.
Heron Therapeutics' projected breakeven and profitability rely on optimistic growth estimates. The company's negative equity, possibly due to accounting methods, raises concerns.
$Heron Therapeutics(HRTX.US)$Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
71129854 :
I had 23k shares of this and sold them to play pdufa with bluebird bio and Andrew messed me up. I picked up some 3k shares today hoping something good comes out so I can average down on BLUE
Trytosaveabit楼主JESSE JAMES8832:
Yeah and the other problem is if it does go bad? I’ve seen these drop so hard and fast on a CRL Responce or a No! That they will blow right passed a stop loss and not trigger! So the way I approach some of them is, I will set a LIT order for a few cents above what it is trading at now. Then hopefully if it’s approved and it starts to go up? My buy is picked up on the way up. But sometimes it will also jump up so fast it Don trigger buy? But at least you’re trying to get a position without risking the huge drop! Because your order won’t fill unless it starts going up! GL
Heron Therapeutics股票讨论区
$Heron Therapeutics(HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia(LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies(THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$赛诺菲安万特(SNY.US)$ & $再生元制药公司(REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
暂无评论